Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Alimta in metastatic HER2-negative breast cancer
NCT02829008Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Apr 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, pemetrexed in breast cancer, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
bevacizumabpemetrexed
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02829008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829008.